Objective: This work establishes an animal model for nonadjustable gastric banding and characterizes the effect of gastric banding on esophageal physiology. Summary Background Data: Obstruction at the esophagogastric junction (EGJ) results in esophageal dilation and aperistalsis. Although laparoscopic gastric banding as a primary treatment of morbid obesity has been widely accepted, the effects of this therapy on esophageal function remain unknown. Methods: Twenty-five opossums were randomly divided into sham (n ϭ 5), EGJ band (n ϭ 5), and gastric band (n ϭ 15) groups. Gastric and EGJ bands were surgically placed, and esophageal manometry was performed prebanding, at 2-week intervals during the banding period (up to 14 weeks), and 2 and 4 weeks after band removal. Results: Manometric measures were equivalent prior to banding in all groups. There were no changes in LES or esophageal pressures during the study period in the sham group. During banding, there was a 36% decrease in baseline mean resting lower esophageal sphincter pressure in the gastric band group (P ϭ 0.003). Mean distal esophageal peristaltic pressure decreased from baseline by 36% in gastric band animals (P Ͻ 0.001). The incidence of esophageal motility disorder during the study period for sham, EGJ band, and gastric band groups, was 2.9%, 42.1%, and 31.3%, respectively (P ϭ 0.001, P ϭ 0.381, pairwise comparisons of gastric band vs. sham and gastric band versus EGJ groups, respectively). Immediately prior to band removal, the probability of an abnormal peristaltic sequence with each swallow was 1%, 38%, and 16% for sham, EGJ, and gastric band groups, respectively (P Ͻ 0.005, pairwise comparisons of band groups with sham). Conclusions: Nonadjustable gastric banding results in impaired esophageal body motility, a reduction in esophageal peristaltic pressure, and a reduction in resting lower esophageal sphincter pressure. These findings suggest that gastric banding causes esoph-ageal outlet obstruction and subsequent decompensation of peristaltic function as well as a compromise of the native antireflux mechanism. (Ann Surg 2006;244: 723-733) From the FIGURE 5. Distal esophageal amplitude over study period. Comparisons at midstudy, 2 weeks prior to band removal, and time of band removal are as follows: EGJ versus sham, P Ͻ 0.001; gastric band versus sham, P Ͻ 0.001. Comparisons at 2 weeks' recovery: EGJ versus sham, P ϭ 0.025; gastric band versus sham, P ϭ 1.0. Comparisons at 4 weeks' recovery: EGJ versus sham, P ϭ 0.342; gastric band versus sham, P Ͻ 0.001.
L aparoscopic gastric banding has become a mainstay of surgical therapy for morbid obesity over the last decade. The first adjustable gastric band device was used in humans in 1986, 1 and gastric banding has subsequently become widely used in Europe and Australia. In 2001, the U.S. Food and Drug Administration approved the first adjustable gastric band device for use in humans, and since then, application of gastric banding has increased in frequency in the United States. An important reason for the increasing popularity of gastric banding is that major morbidity and mortality are at least 10-fold less than that associated with gastric bypass and malabsorptive procedures. 2, 3 Despite these advantages, concerns remain regarding the long-term sequelae of gastric banding. A major concern is the effect of gastric banding on esophageal function. Gastric banding establishes a relative outlet obstruction of the esophagus and proximal stomach, and the long-term effects of such obstruction on esophageal motility and lower esophageal sphincter (LES) function remain unknown. Motility disorders in both animals and humans have been well described following placement of bands at the esophagogastric junction (EGJ). 4 -10 Esophageal dysmotility has also been noted following gastric banding in humans 11, 12 but has not been studied on a prospective basis, nor has it been studied in animal models. When esophageal dysmotility does develop, it can be a disabling condition. While rare, it is important to be vigilant for such complications in gastric band patients. Obesity is independently associated with an increased prevalence of abnormal esophageal function, [13] [14] [15] [16] and is probably an independent risk factor for gastroesophageal reflux disease (GERD) as well. [15] [16] [17] [18] [19] It is therefore critical to understand the effect of bariatric surgical procedures on esophageal and LES function in this patient population at high risk for esophageal dysfunction in the first place.
The North American opossum (Didelphis virginiana) represents an excellent model for the study of human esophageal physiology. 19 The opossum foregut is closely analogous to the human foregut with respect to the proportion of smooth and skeletal muscle and intrinsic motor function. 20 In addition, the opossum esophagus is large enough to allow for accurate manometric and radiographic evaluation. Normal opossum esophageal motility was characterized by Schulze et al in 1977 . 20 Subsequently, the opossum model has been used to study esophageal dysmotility in an obstructive model that reproduces the clinical and manometric features of achalasia. 4 Khajanchee et al found severe dysmotility culminating in aperistalsis caused by band placement around the esophagogastric junction, effectively preventing receptive relaxation of the LES. 4 Whether a functional obstruction immediately distal to the EGJ has the same effect is unknown.
This study uses an in vivo opossum model to explore the effects of nonadjustable gastric banding on esophageal and LES function. Our specific aims are to establish an animal model for gastric banding, to identify changes in esophageal and LES function following gastric banding and to assess recoverability of alterations in esophageal function after band removal.
METHODS

Study Design and Overview
This study was approved by the Institutional Animal Care and Use Subcommittee at the Portland Veteran's Administration Medical Center. After a 2-week acclimation period, 25 wild adult opossums (Didelphis virginiana) were divided into sham (n ϭ 5), EGJ band (n ϭ 5), and gastric band (n ϭ 15) groups.
Animals were banded for a period of up to14 weeks during which they were monitored for an esophageal motility disorder. The band was removed prior to 14 weeks for greater than 30% loss of baseline body weight or significantly reduced food intake. Sham animals underwent 2 laparotomies, which simulated band placement and removal. The second sham laparotomy was performed 14 weeks after the initial sham procedure ( Fig. 1 ). Esophageal manometry was performed on all animals at baseline (preband placement), at 2-week intervals during the banding period, immediately prior to band removal, and at 2 and 4 weeks after band removal. At the conclusion of the study period, animals were killed and underwent necropsy.
Weights were recorded biweekly, as were clinical signs of obstruction or esophageal motility disorder, including gagging, coughing, or regurgitation. Oral intake was rated as "normal," "reduced," or "significantly reduced." Normal oral intake was defined as consumption of Ͼ70% of food in cage per day, reduced intake as 70% to 50% consumption, and significantly reduced intake as Ͻ50% consumption of daily food allotment.
Manometry
Manometry was performed under monitored sedation with inhaled isoflurane. A four-channel solid-state manometry catheter (Sandhill Scientific, Highlands Ranch, CO) was placed transorally through a secured bite block. After establishing the gastric baseline, a stationary pull-through technique was used to measure LES resting pressure, length, position, and relaxation using established criteria. 21 A Ͼ2-mm Hg rise in pressure from the gastric baseline identified the distal border of the LES, while the proximal border of the LES was identified by a drop in pressure below gastric baseline. The LES resting pressure was defined by the pressure at the respiratory inversion point during midrespiration. LES relaxation was assessed with the distal transducer placed within the middle of the LES, and hypopharyngeal stimulation was used to induce dry swallows. LES relaxation was defined as the percent relaxation to Ͻ8 mm Hg for 10 swallows. Esophageal body motility at 3, 5, 7, and 9 cm proximal to the upper border of the LES was recorded over 10 swallows. Esophageal body tracings were analyzed for sequence progression, wave morphology, velocity (cm/s), and contraction amplitude (mm Hg).
Gastric Band Design and Operative Technique
The band consisted of a length of hollow silicone drain tubing, with 2 #2 silk sutures passed within the tubing. Once in position in the abdomen, the silk sutures were loosely tied, creating the circular band. Each band was then calibrated to a luminal diameter of 6.7 mm using a transoral 20-Fr internal esophageal stent. A 1-cm length of over-tubing was designed to cover the junction of the opposed ends of the band to prevent erosion ( Fig. 2A) .
The opossum gastric band was designed to approximate the upper limit of luminal area (ie, nearly deflated) of the human band device, using distal esophageal cross-sectional area as a measure of proportional size between human and opossum. The average luminal diameter of the human esophagus is 24 mm. 22 The average luminal diameter of the opossum esophagus is 8.6 mm, based on measurements from opossum necropsy specimens obtained prior to this study. Human and opossum esophageal diameter translate to a cross-sectional area of 452 mm 2 and 58 mm 2 , respectively, a ratio of cross-sectional area (human/opossum) of 7.8. The inner area of the 10 cm human band device (Inamed Corporation, Santa Barbara, CA) ranges from 250 mm 2 in the fully inflated state to 550 mm 2 in the deflated state (Inamed Corporation product literature). Assuming a conservative estimate of human gastric wall thickness of 3 mm, the luminal area of the stomach within the band therefore ranges from 100 to 300 mm 2 . The opossum band was created over a 20-Fr stent, which corresponds to a luminal area of 35 mm 2 . Using the proportional ratio of 7.8, the opossum band corresponds to a human luminal area of 273 mm 2 .
Animals underwent general endotracheal anesthesia with isoflurane using standard intraoperative monitoring procedures. The abdominal cavity was accessed through a mid-line incision. A 20-Fr esophageal stent was passed transorally into the stomach. For the sham and the gastric band groups, a clamp was passed from the proximal aspect of the lesser curvature at the base of the crura posterior to the stomach and exited 1 cm distal to the angle of His along the greater curvature. At this point, the sham operation was completed and the abdomen closed. For the gastric band group, the band was guided through the dissection plane. The 2 ends of the band were approximated with the silk sutures, band diameter adjusted, and the sutures were tied over the stent. A circumferential gastrogastric fundoplication was performed to prevent slippage (Fig. 2B ). EGJ bands were placed around the distal esophagus immediately proximal to the EGJ over a 20-Fr esophageal stent. The vagus nerves were not elevated or manipulated. To prevent migration, the inferior aspect of the band was sutured to the EGJ with 2 interrupted seromuscular sutures. Animals were fed a soft diet for the first week following surgery. Animals were given intravenous antibiotics and narcotics for 48 hours after surgery.
Barium Swallow Technique
A contrast esophagram protocol was developed and performed in a representative sample of animals at baseline, and immediately prior to EGJ (n ϭ 2) or gastric (n ϭ 2) band removal. Opossums were placed prone with the head slightly elevated. To prevent aspiration of contrast, an endotracheal tube with a balloon was used. Under fluoroscopy, barium sulfate was instilled directly into the proximal esophagus via a small catheter and a swallow was initiated by stimulating the hypopharynx. At the completion of the examination and prior to extubation, excess barium was suctioned from the esophagus and oropharynx.
Manometric Endpoints and Data Analysis
Esophageal amplitude was calculated for each of the 4 esophageal body channels for individual swallows in mm Hg. Abnormal sequence progression was defined as the presence of interrupted, dropped, tertiary, or simultaneous contractions, or aperistalsis after a swallow. Interrupted sequences were defined as an initial contraction followed by no detectable contraction, with a waveform reappearing distally. Dropped peristalsis was defined as loss of a detectable contraction with no reappearance of the waveform. Disordered and tertiary contractions were defined as loss of aboral peristalsis, with distal contractions appearing prior to proximal contractions, or the presence of random contractions without a swallow. Simulta- 
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A Model for Gastric Banding neous contractions were defined as contractions with a progression rate of Ͼ20 cm/s. Aperistalsis was defined by the absence of detectable contractions (Ͻ10 mm Hg) following a swallow. 21 Abnormal wave morphology was defined as multipeaked, repetitive, or prolonged waves, or the presence of elevated ramp intrabolus pressure. 21 Multipeaked contractions were defined as 2 or more peaks in a single contraction in which the waveform did not return to baseline between peaks, and in which the secondary peak duration was longer than 1-second and amplitude was greater than 10% of the primary contraction. Repetitive contractions were defined by the same criteria, but with a return to baseline between consecutive peaks. A ramp intrabolus pressure, an indicator of outflow resistance, was defined by the presence of a "shoulder" wave form that immediately precedes the peristaltic upstroke after a swallow. 21, 23 Because the animals in the study groups were banded for variable lengths of time (2-14 weeks), data were categorized into 6 time periods: baseline (prebanding), midstudy, 2 weeks prior to removal, at band removal, and 2 and 4 weeks after band removal. Midstudy data consisted of a compilation of all data for each animal between the baseline manometry and the manometry 2 weeks prior to band removal. The measured manometric endpoints were LES resting pressure (mm Hg), percent LES relaxation, LES length (cm), and distal esophageal body amplitude (mm Hg); the mean and standard errors of the mean of these endpoints were calculated for each animal at each time period.
Every swallow was examined for sequence progression and morphology. The total number of interrupted, dropped, disordered or tertiary, simultaneous, and aperistaltic waveforms that occurred during the banding period were calculated as a percentage of the total number of swallows during this period. An esophageal motility disorder was considered present if sequence abnormalities were recorded in Ͼ 10% of swallows for any given manometry. Wave morphology abnormalities did not contribute to the diagnosis of a motility disorder.
Statistical Analysis
One-way ANOVA with posthoc Tukey analysis was used to compare weights between groups. 2 analysis was used to compare the incidence of clinical signs of esophageal motility disorder and food intake between groups. A Kaplan-Meier survival curve comparing groups with log-rank test was used to compare time to band removal, median time to the development of an esophageal motility disorder, and median duration of banding after the development of an esophageal motility disorder between EGJ and gastric band groups. Independent t test was used to compare LES length, resting pressure, percent relaxation, and distal esophageal amplitude within study groups. Manometric endpoints between study groups, including LES resting pressure, length, percent relaxation, and distal esophageal body amplitude were compared using a one-way ANOVA with posthoc Bonferroni analysis. To adjust for variation within each animal for outcomes or time-points with multiple measures per animal, a two-factor ANOVA with post hoc Bonferroni analysis was used. The prevalence of manometric abnormalities was compared using a 2 test, with posthoc pairwise comparisons made using Fisher exact test.
A binomial logistic mixed effects model was fit on the data with a single fixed effect for study group (sham, EGJ band, and gastric band) and a single random effect for experimental subject. At each evaluation, the number of abnormalities and the number of swallows was recorded. The rate of abnormality per swallow at each evaluation was the outcome variable in our statistical model. The model was fit using WinBUGS with noninformative prior distributions. 24 An alpha value of 0.05 defined statistical significance.
RESULTS
Clinical Course
At baseline, the mean initial weight of the sham animals was 4.0 kg, which was less than that of EGJ banded (4.4 kg) and gastric band (5.0 kg) animals (P ϭ 0.618 and P ϭ 0.032, respectively). Four of 5 sham animals gained weight during the interval between initial and final sham procedures (ϩ25% change in body weight; absolute mean increase of 0.9 kg). All of the EGJ band animals and 13 of 15 gastric band animals lost weight during the banding period (Ϫ22% and Ϫ18% change in body weight respectively; absolute mean weight loss 1.0 kg and 0.9 kg, respectively). Weight loss between gastric band and EGJ band groups was not different (P ϭ 0.879), while weight loss between sham and gastric band groups, and sham and EGJ band groups, was significantly different (P ϭ 0.001 and P ϭ 0.003, respectively). After band removal, the mean weight gain for EGJ band and gastric band animals was 0.6 kg, and 0.2 kg, respectively.
Clinical evidence of dysmotility or obstruction (ie, documented episodes of emesis or gagging) developed in all EGJ banded animals and in 7 of the 15 gastric band animals, while no shams demonstrated these signs (P ϭ 0.007). Although esophageal motility disorders occurred in all gastric band animals with clinical signs of obstruction, some animals without clinical signs also developed an esophageal motility disorder ( Table 1) . Food intake was significantly less in banded animals when compared with shams (P ϭ 0.009). Among sham animals, 96% had "normal" oral intake and 4% had "reduced" oral intake at all time-points during the study period. In the EGJ banded group, intake was determined to be "reduced" and "significantly reduced" in 36% and 27% of animals, respectively. Within the gastric band group, food intake was recorded as "reduced" in 16% and "significantly reduced" in 11% of animals.
Banding Duration and Development of Esophageal Motility Disorder
The median banding period for EGJ and gastric band groups was 6 weeks (interquartile range ͓IQR͔, 3-13 weeks) and 12 weeks (IQR, 2-14 weeks), respectively (P ϭ 0.446). Of the EGJ banded group, 4 of 5 underwent band removal prior to 14 weeks. Nine of fifteen gastric band animals underwent band removal prior to 14 weeks ( Table 1) . All bands were discovered to be in proper position at the time of removal. The median time to the development of an esoph-ageal motility disorder for EGJ banded and gastric band groups was 2 weeks (IQR, 2-7 weeks) and 6 weeks (IQR, 2-10 weeks), respectively (P ϭ 0.687). The median duration of banding after the development of an esophageal motility disorder was 2 weeks (IQR, 1-7 weeks) for the EGJ band group and 4 weeks (IQR, 2-6 weeks) for gastric band animals (P ϭ 0.932).
Mortality
All sham animals survived for the entire study period. One animal in the EGJ band group and 5 animals in the gastric band group died after band removal and prior to completion of the 4-week recovery period. The EGJ band animal died 2 weeks after band removal from severe right heart failure secondary to parasitic tricuspid valve disease. Two gastric band animals died of sepsis (likely parasitic in etiology) shortly after band removal. In these animals, bands were in proper position with patent lumens which admitted passage of a 20-Fr esophageal stent. One gastric band animal had gastric distension on necropsy, but no perforation or obstruction. Another gastric band animal died of ischemic colon related to hypoperfusion secondary to cardiac disease. Finally, one gastric band animal died of intra-abdominal sepsis due to a perforation at one of the previously placed gastrogastric sutures.
Barium Esophagram
Barium esophagram was technically successful in all (4 of 4) animals. Studies demonstrated the radiographic appearance of EGJ and gastric bands; contrast passed easily through the narrowing created by the band. There was evidence of esophageal dilation at the time of band removal in both EGJ band and gastric band animals ( Fig. 3 ).
Manometric Evaluation-LES
A total of 186 manometric studies were performed in this investigation (50 sham, 33 EGJ band, and 103 gastric band). A total of 1746 swallows were analyzed throughout the duration of this study. During banding, LES resting pressure (LESRP) increased in EGJ banded animals and decreased in gastric band animals. EGJ banded animals demonstrated an LESRP that was 57% greater than the sham animals at midstudy (P Ͻ 0.001), 61% greater at 2 weeks prior to band removal (P ϭ 0.054), and 85% greater at band removal (P ϭ 0.026) (Fig. 4A ). Gastric band animals demonstrated LESRP, which was 23% less than the sham animals at midstudy (P ϭ 0.002), 25% less at 2 weeks prior to band removal (P ϭ 0.596), and 33% less at band removal (P ϭ 0.524). Within the gastric band group, there was a 36% decrease in LESRP from baseline during the banding period (P ϭ 0.003). LESRP returned to normal after band removal in all groups.
LES relaxation was impaired in both EGJ banded and gastric band groups during the banding period. In the EGJ banded group, percent LES relaxation was 15% less than sham animals at midstudy (P ϭ 0.212), 50% less at 2 weeks prior to band removal (P ϭ 0.001), and 12% less at band removal (P ϭ 0.538) ( Fig. 4B) . Similarly, percent LES relaxation was 17% less in the gastric band animals compared with sham animals at midstudy (P ϭ 0.005), 8% less at 2 weeks prior to band removal (P ϭ 1.0), and 12% less at band removal (P ϭ 0.311). This represents a 12% decrease in percent LES relaxation from baseline to band removal timepoints within the gastric band group (P ϭ 0.006). LES relaxation returned to normal after band removal in all groups.
LES length did not change substantially in any group over the course of the study and did not differ significantly among groups at any time-point (Fig. 4C ).
Manometric Evaluation-Esophageal Body
During the banding period, contraction amplitude within the esophageal body decreased in both EGJ band and gastric band groups. Compared with sham animals, distal esophageal amplitude was 28% less in EGJ banded animals at midstudy, 30% less at 2 weeks before band removal, and 51% less at band removal time-points; all comparisons with shams were significantly different (P Ͻ 0.001). This represents a 47% 
EMD § (Y/N)
*Defined as any weight loss during the banding period. † Defined as any regurgitation or emesis during the banding period. ‡ Animals that underwent band removal (BR) prior to 14 wk had Ͼ30% weight loss or poor intake. § Esophageal motility disorder (EMD) detected on any single manometry during banding or recovery period. BR indicates band removal; GB, gastric band group; EGJ, esophagogastric junction band group.
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A Model for Gastric Banding decrease in distal esophageal amplitude from baseline to band removal time-points within the EGJ group (P Ͻ 0.001) ( Fig.  5 ). In gastric band animals, the distal esophageal amplitude was 26% less than shams at midstudy, 35% less at 2 weeks before band removal, and 40% less at band removal; all comparisons with shams were significantly different (P Ͻ 0.001). This represents a 36% decrease in distal esophageal amplitude from baseline to band removal time-points within the gastric band group (P Ͻ 0.001). These values improved after band removal in both gastric band and EGJ banded animals. After 4 weeks of recovery, however, the EGJ banded group demonstrated 9% lower distal esophageal amplitude when compared with the sham group (P ϭ 0.342), while the gastric band group demonstrated 19% lower distal esophageal amplitude than shams (P Ͻ 0.001). One sham, all EGJ animals, and 11 of 15 gastric band animals exhibited an esophageal motility disorder on at least one manometric study during banding or recovery periods ( Table 1 ). The incidence of esophageal motility disorders during the banding period (number of esophageal motility disorders per total number of manometry studies) for sham, EGJ band, and gastric band groups, was 2.9%, 42.1%, and 31.3%, respectively. In terms of the specific types of esophageal motility disorders, gastric band animals exhibited primarily interrupted peristalses, whereas the EGJ group demonstrated an even distribution of tertiary, simultaneous, and aperistaltic contractions ( Table 2) . No sham animals developed aperistalsis. In contrast, 5.7% of EGJ banded animals and 2.9% of the gastric band group exhibited aperistalsis, and this was significantly different from sham animals in pairwise comparisons (P ϭ 0.001).
There was no difference in the frequency of multipeaked, repetitive, or prolonged esophageal body waveforms among groups during banding. However, EGJ banded animals exhibited significantly more ramp intrabolus pressure episodes than sham animals (9.2% vs. 0% of all swallows during banding, P Ͻ 0.001) and gastric band animals (1.9%, P Ͻ 0.001). The difference in the frequency of ramp intrabolus pressure episodes between gastric band and sham animals was also significantly different (1.9% vs. 0%, P ϭ 0.011).
The probability of an abnormal sequence progression or abnormal wave morphology for any given swallow was determined for each group of animals ( Fig. 6 ). Sham animals demonstrated a 1.08% probability of abnormal sequence progression for any given swallow. At the time of band removal, the probability of an abnormal sequence progression in EGJ banded and gastric band animals was 38.14% ͓P ϭ 0.003 (vs. sham)͔ and 15.92% ͓P ϭ 0.005 (vs. sham)͔, respectively. The sham group demonstrated a 4.18% probability of abnormal wave morphology for any given swallow at 14 weeks. By comparison, the probability of abnormal wave morphology with each swallow was 15.89% in EGJ band animals and 3.32% in gastric band animals. When comparisons were made among the 3 groups, the only significant difference was between EGJ and gastric band groups (P ϭ 0.045).
DISCUSSION
Gastric banding is becoming an increasingly important tool in the bariatric surgical armamentarium. Long-term follow-up with objective evaluation of esophageal function in gastric band patients is lacking, however, and concerns exist regarding the effects of this procedure on esophageal function. Parallels between current gastric band devices and the now abandoned Angelchik device 25 have resulted in persistent skepticism toward gastric banding. Current gastric band devices benefit from decades of advances in prosthetic device engineering, however, and this, coupled with advances in surgical technique, suggests that the effects of gastric banding on esophageal function warrants renewed examination. We therefore developed an in vivo opossum model to study the effects of nonadjustable gastric banding on esophageal function. The primary finding of this study is that gastric banding is associated with the development of abnormalities in esophageal function, including decreased esophageal and LES pressures accompanied by abnormal esophageal body peristalsis.
Obesity, Gastric Banding, GERD, and Esophageal Motility Disorders
Despite continuing debate regarding the role of obesity in the development of GERD, 26 accumulating evidence sug- All other time-points and differences did not reach statistical significance. A, LES resting pressure (mm Hg). B, LES percent relaxation. C, LES length (cm). No significant differences were noted between any groups at any time-points with respect to LES length.
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A Model for Gastric Banding gests that increased body mass contributes to impairment of both the antireflux barrier and intrinsic esophageal function.
While early studies showed no correlation between BMI and GERD, 27, 28 more recent studies identify obesity as an independent risk factor for GERD. 14 -18,29 Whether obesity is also a risk factor for esophageal motility disorders is a separate, albeit related question, but growing evidence suggests that obesity is associated with an increased prevalence of esophageal dysfunction. [13] [14] [15] The effects of gastric banding on GERD and esophageal function are likewise not well studied. While isolated early reports demonstrated worsening GERD symptoms after gastric banding, 30, 31 these studies are conflicting. Øvrebø et al 30 demonstrated exacerbation of GERD symptoms in gastric band patients but used a nonadjustable Dacron gastric band, a qualitatively different device than the modern gastric band. Korenkov et al demonstrated no change or improvement in pre-existing GERD symptoms after gastric banding in some patients, while others experienced new onset GERD symptoms. 31 In contrast to these data, the majority of recent studies demonstrate fairly consistent improvement of symptoms and objective evidence of GERD after gastric banding. 12, [32] [33] [34] [35] These conflicting data may be due to differences in surgical technique, preexisting esophageal dysfunction in some patients, or other clinical factors.
Despite evidence suggesting that gastric banding leads to resolution of GERD, such resolution does not necessarily imply protection from the development of esophageal motility disorders. The relative esophageal outlet obstruction created by gastric banding might prevent acid reflux cephalad to the band while nonetheless impairing esophageal and LES motor function. Only sparse data addresses this issue in humans. Weiss et al found that gastric banding led to impairment of LES relaxation. 12 Peternac et al also demonstrated abnormal esophageal motility after gastric banding, although the use of contrast studies rather than manometry to identify abnormal motility limited the specificity of their analysis. 11
The Opossum Model of Gastric Banding
The paucity of human data addressing the effect of gastric banding on esophageal function, and the difficulties in performing such studies in humans, suggest a role for animal models of gastric banding. We developed this in vivo opossum model of nonadjustable gastric banding to allow for in-depth study of esophageal function.
There are potential limitations associated with this model. Esophageal manometry in humans is performed without sedation, and anesthetic agents have been shown to affect esophageal function. Nevertheless, this variable was internally controlled for in these experiments, in that preoperative manometry was also performed with sedation. Another limitation of this study is that this animal model does not incorporate obesity. While it is tempting to speculate that obese humans, with a higher baseline prevalence of esophageal dysfunction, [13] [14] [15] might be at higher risk for esophageal motility disorders after gastric banding than the lean animals in this study, unknown counterintuitive effects of obesity on esophageal function might attenuate detrimental effects of gastric banding on the esophagus. Development of an animal model of gastric banding that incorporates obesity will address this issue.
An important limitation of this in vivo model is the nonadjustable nature of the gastric band, and the lack of symptomatic patient feedback regarding band outlet area. Fine titration of band diameter based on mild dysphagia symptoms is not possible in this model. All EGJ animals, and 47% of gastric band animals, demonstrated regurgitation and gagging, signs that may suggest an overly tight or malpositioned band. In addition, the esophagram in the gastric band animal demonstrated a horizontal band position and a rela-tively large gastric pouch, which in humans would indicate a malpositioned band. Although 87% of gastric band animals lost weight during the banding period, a high proportion of this group had "normal" food intake recorded. This strong stimulus for feeding may have indicated the presence a large gastric pouch or unremitting hunger secondary to frequent regurgitation caused by a tight band. Conversely, opossums are probably less likely than humans to limit food intake based on gastric pouch outlet restriction, and may lack the ability to consciously limit food intake based on subtle 
FIGURE 6.
Probability of abnormal sequence progression and abnormal wave morphology for any given swallow at the time of band removal. The bars represent 95% confidence intervals about the mean. Abnormal sequence progression included interrupted, dropped, simultaneous, or disordered contractions, and aperistalsis. Significant differences in probability of abnormal sequence progression were observed between sham and EGJ banded groups (P ϭ 0.003) and between sham and gastric band groups (P ϭ 0.005). Abnormal wave morphology included multipeaked, repetitive, prolonged waves, and ramp intrabolus pressure. Significant differences in probability of abnormal wave morphology were observed between EGJ banded and gastric band groups (P ϭ 0.045).
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A Model for Gastric Banding restrictive symptoms. Such qualitative differences in satiety mechanisms may have caused animals to eat to the point of overfilling their gastric pouches and this, rather than an overly tight or malpositioned band, may have led to regurgitation and gagging. Currently, insufficient data exist to define the radiographic appearance of a properly positioned gastric band in an opossum. Further study will be required to understand the relationship between band position and luminal area in the development of an esophageal motility disorder. These data support the need for careful management of band diameter in the postoperative setting.
Effects of Gastric Banding on Esophageal Function
The mechanisms involved in the development of GERD and esophageal motility disorders after gastric banding remain unknown. The relative outlet obstruction created by gastric banding likely leads to proximal postprandial pouch distention, which may in turn lead to chronic distension of the LES and distal esophagus, with subsequent LES dysfunction and esophageal dilation. Distal outflow obstruction has been shown to lead to esophageal motility disorders and a clinical picture similar to achalasia in animal models of EGJ banding 4 -10 and in humans after tight Nissen fundoplication. 36 With respect to GERD, retention of food in the pouch and distal esophagus may lead to acidic fermentation in the distal esophagus, similar to the pseudoreflux associated with achalasia. 37 Differences in the resolution of GERD after gastric banding might be explained by variability in the number of acid-secreting parietal cells in the fundus that are retained in the proximal gastric pouch. Anatomic differences in the number of parietal cells in the proximal stomach, 38 or subtle variations in operative technique may account for differences in the inclusion of pouch parietal cells. Differences in the point of entry of the band with respect to the base of the crura probably result in differences in pouch size and band angle. Others have demonstrated such differences in band positioning in gastric band patients and attempted to correlate such differences with the risk of subsequent pouch dilation. 11 Of interest, EGJ animals demonstrated significantly more simultaneous contractions and aperistalsis, while gastric band animals demonstrated more interrupted and dropped peristalses. The former suggests a more advanced and severe form of esophageal motility disorder, while the latter is consistent with an early-stage esophageal motility disorder. This suggests that progression to severe esophageal motility disorders may be delayed after gastric banding compared with EGJ banding. Banding below the EGJ may lead to a "cushion effect" in which the distensible proximal gastric pouch acts as a reservoir below the partially obstructed esophagus, off-loading stress on the distal esophagus and thus delaying onset of severe esophageal motility disorder. This theory is supported by the fewer episodes of ramp intrabolus pressure observed in the gastric band group when compared with EGJ animals. The short banding periods after the development of an esophageal motility disorder likely contributed to the reversibility of esophageal motility disorders. It is possible that long-term banding in humans could lead to irreversible esophageal motility disorders. In addition, baseline LES resting pressure decreased by 36% in gastric band animals, suggesting that chronic distention and stretching of the musculature comprising the LES occurred proximal to the gastric band. Unexpectedly, LES length did not decrease in parallel with a reduction in LES resting pressure. Using our solid-state manometry system, LES length in the opossum may be too short to detect subtle changes with adequate sensitivity.
Long-term Effects of Gastric Banding on Esophageal Function in Humans
Gastric banding has significant advantages over gastric bypass and malabsorptive procedures with respect to morbidity and mortality, and is an effective tool for achieving weight loss. 2, 3 The development of esophageal motility disorders in gastric band patients must be balanced with these important benefits. An important related finding of this study is that alterations in esophageal function improved with band removal. This suggests that routine monitoring of esophageal function after gastric banding may be warranted. Band removal would be considered in patients who develop esophageal motility disorders, based on the premise that such alterations, if identified early, are reversible. In this study, early band removal may have prevented progression to irreversible changes in motility. It is unlikely such early removal could be accomplished in humans, especially if associated with mild or absent symptoms in the early period of development of an esophageal motility disorder. Twenty-seven percent of gastric band animals in this study developed an esophageal motility disorder without developing regurgitation or gagging, suggesting that esophageal motility disorders may develop in the absence of symptoms. The effects of gastric banding on esophageal function decades later are unknown, and it cannot be assumed that humans will present with symptoms to forewarn the onset of esophageal motility disorders prior to the point of irreversibility. These observations are especially important in light of the progressively younger patient population in which gastric banding is being applied. Only long-term studies in humans will determine the extent, severity, and reversibility of esophageal motility disorders associated with gastric banding.
Compared with initial U.S. trials, 3, 39 recent studies have shown much lower rates of esophageal dilation after gastric banding in humans, 40, 41 and esophageal motility disorders have not been reported in international series. 2, 3 Whether long-term follow-up will reveal a higher prevalence of esophageal motility disorders after gastric banding is currently unknown. More likely, we feel that a subset of patients is at risk for the development of esophageal motility disorders and GERD after gastric banding. Variability in the resolution of GERD symptoms after gastric banding 31 supports this hypothesis. Such differences may be due to variability in the number of acid-secreting parietal cells in the proximal gastric pouch, the presence of preexisting esophageal or LES dysfunction, subtle differences in operative technique, or some combination of these or other factors. Similar risk factors may exist for the development of esophageal motility disorders after gastric banding. Identification of such high-risk patients would allow for consideration of alternative procedures, or at least identify patients who warrant postoperative esophageal monitoring. Of interest, others have identified risk factors predictive of other serious complications after gastric banding. Greenstein et al identified hiatal hernia and preexisting esophageal motility disorders as risk factors for band slippage. 42 These data combined with our findings suggest that preexisting esophageal motility disorders should be considered a relative contraindication to gastric banding.
CONCLUSION
These experiments establish an animal model for the study of the effects of nonadjustable gastric banding on esophageal physiology. These data raise concern that gastric banding may adversely affect esophageal peristaltic function and the antireflux barrier, and that esophageal dysfunction may occur in the absence of symptoms. Prospective esophageal function testing of gastric band patients will define the long-term effects of partial gastric outlet obstruction on esophageal and LES function, and identify predictors of a maladaptive response to gastric banding.
